Andrew J. Murphy, EVP Research at REGENERON PHARMACEUTICALS, INC. (REGN), sold 4,760 shares at $630.77 ($3.0M) on 2020-07-14, disclosed to the SEC on 2020-07-15.
Open-market sale of $3.0M REGN by EVP Research. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $630.77 | 264 | $167K | 5.5% |
| 2 | $630.77 | 264 | $167K | 5.5% |
| 3 | $631.32 | 578 | $365K | 12.1% |
| 4 | $631.32 | 578 | $365K | 12.1% |
| 5 | $632.12 | 679 | $429K | 14.2% |
| 6 | $632.12 | 679 |
| $429K |
| 14.2% |
| 7 | $633.02 | 95 | $60K | 2.0% |
| 8 | $633.02 | 95 | $60K | 2.0% |
| 9 | $634.18 | 89 | $56K | 1.9% |
| 10 | $634.18 | 89 | $56K | 1.9% |
| 11 | $635.46 | 175 | $111K | 3.7% |
| 12 | $635.46 | 175 | $111K | 3.7% |
| 13 | $637.48 | 182 | $116K | 3.8% |
| 14 | $637.48 | 182 | $116K | 3.8% |
| 15 | $638.96 | 239 | $153K | 5.1% |
| 16 | $638.96 | 239 | $153K | 5.1% |
| 17 | $639.55 | 79 | $51K | 1.7% |
| 18 | $639.55 | 79 | $51K | 1.7% |
| Total | $633.48 avg | 4,760 | $3.0M | 100% |
| Filing → |
| REGN | SELL | 2024-03-15 | $11.0M | — | Filing → |
| REGN | SELL | 2023-12-06 | $10.6M | — | Filing → |
| REGN | SELL | 2023-11-15 | $10.3M | — | Filing → |